Bio-Techne Corp [TECH] stock prices are up 5.72% to $57.09 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TECH shares have gain 6.51% over the last week, with a monthly amount drifted -2.36%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bio-Techne Corp [NASDAQ: TECH] stock has seen the most recent analyst activity on August 21, 2025, when Citigroup upgraded its rating to a Buy but kept the price target unchanged to $70 for it. On July 09, 2025, TD Cowen initiated with a Buy rating and assigned a price target of $65 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $59 on May 30, 2025. KeyBanc Capital Markets downgraded its rating to a Sector Weight. Evercore ISI started tracking with a Outperform rating for this stock on March 18, 2025, and assigned it a price target of $75. In a note dated February 19, 2025, Robert W. Baird downgraded a Neutral rating on this stock and revised its target price from $88 to $68.
The stock price of Bio-Techne Corp [TECH] has been fluctuating between $46.01 and $80.95 over the past year. Currently, Wall Street analysts expect the stock to reach $75 within the next 12 months. Bio-Techne Corp [NASDAQ: TECH] shares were valued at $57.09 at the most recent close of the market. An investor can expect a potential return of 31.37% based on the average TECH price forecast.
Analyzing the TECH fundamentals
The Bio-Techne Corp [NASDAQ:TECH] reported sales of 1.22B for trailing twelve months, representing a surge of 3.55%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.06 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 55.12 points at the first support level, and at 53.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 58.24, and for the 2nd resistance point, it is at 59.40.
Ratios To Look Out For
It’s worth pointing out that Bio-Techne Corp [NASDAQ:TECH]’s Current Ratio is 3.46. In addition, the Quick Ratio stands at 2.38 and the Cash Ratio stands at 0.92. Considering the valuation of this stock, the price to sales ratio is 7.34, the price to book ratio is 4.61 and price to earnings (TTM) ratio is 125.89.
Transactions by insiders
Recent insider trading involved Herr Amy E., Director, that happened on Jun 09 ’25 when 1280.0 shares were sold. Officer, JOSHUA MOLHO completed a deal on Jun 09 ’25 to buy 1280.0 shares. Meanwhile, Director Herr Amy E. sold 1860.0 shares on Feb 14 ’25.
